Charles A. III Reinhart
CIK 1470871 · Chief Financial Officer · last filed 2024-06-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.19M
Companies
2
Total Filings
17
Lifetime Open-Market Net
-$556.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCRX | Chief Financial Officer | 51,867 | $22.99 | $1.19M | -$556.0K | 15 | 2024-06-13 |
| Altimmune, Inc. (PIP) Delisted | SVP, Chief Financial Officer | — | — | — | $0 | 2 | 2010-12-10 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-15 | PCRX | Grant (A) | +5,000 | $0 | EDGAR |
| 2018-06-06 | PCRX | Sell (S) | −708 | -$23.4K | EDGAR |
| 2017-06-16 | PCRX | Grant (A) | +8,750 | $0 | EDGAR |
| 2016-12-09 | PCRX | Grant (A) | — | $0 | EDGAR |
| 2016-05-04 | PCRX | Grant (A) | — | $0 | EDGAR |
| 2010-12-10 | Altimmune, Inc. (PIP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-05-10 | Altimmune, Inc. (PIP) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.